Marron, S.E.; Tomas-Aragones, L.; Moncin-Torres, C.A.; Gomez-Barrera, M.; Aranibar, F.J.G.-L.d.
Patient Reported Outcome Measure in Atopic Dermatitis Patients Treated with Dupilumab: 52-Weeks Results. Life 2021, 11, 617.
https://doi.org/10.3390/life11070617
AMA Style
Marron SE, Tomas-Aragones L, Moncin-Torres CA, Gomez-Barrera M, Aranibar FJG-Ld.
Patient Reported Outcome Measure in Atopic Dermatitis Patients Treated with Dupilumab: 52-Weeks Results. Life. 2021; 11(7):617.
https://doi.org/10.3390/life11070617
Chicago/Turabian Style
Marron, Servando E., Lucia Tomas-Aragones, Carlos A. Moncin-Torres, Manuel Gomez-Barrera, and Francisco Javier Garcia-Latasa de Aranibar.
2021. "Patient Reported Outcome Measure in Atopic Dermatitis Patients Treated with Dupilumab: 52-Weeks Results" Life 11, no. 7: 617.
https://doi.org/10.3390/life11070617
APA Style
Marron, S. E., Tomas-Aragones, L., Moncin-Torres, C. A., Gomez-Barrera, M., & Aranibar, F. J. G. -L. d.
(2021). Patient Reported Outcome Measure in Atopic Dermatitis Patients Treated with Dupilumab: 52-Weeks Results. Life, 11(7), 617.
https://doi.org/10.3390/life11070617